Some studies have demonstrated that Langerhans cell histiocytosis (LCH) is a neoplastic hyperplasia of Langerhans cells, however some researchers consider that clonality should be assessed in more patients with LCH, both at disease presentation and during the disease course. Monoclonality is a major characteristic of most tumours, whereas normal tissue and reactive hyperplasia are polyclonal. To elucidate the nature of Langerhans cells further, the present study investigated the clinicopathological features and clonality of three cases of LCH in female patients using laser microdissection and a clonality assay, based on X-chromosomal inactivation mosaicism in somatic tissues and polymorphism of the androgen receptor gene. The results indicated that LCH was composed of Langerhans cells with a characteristic morphological appearance, eosinophils, giant cells, neutrophils and foamy cells. Immunohistochemically, the Langerhans cells were positive for CD1a, S-100 protein and vimentin. The clonality assay demonstrated that the Langerhans cells formed a monoclonal population, showing that LCH is neoplastic. We conclude that LCH is characterized by clonal proliferation, although additional studies with larger sample sizes are required to prove this conclusively.
Introduction
Langerhans cell histiocytosis (LCH), formerly known as histiocytosis X or eosinophilic granuloma, is a rare disorder that is characterized by clonal proliferation and excess accumulation of pathological Langerhans cells causing local or systemic effects. 1 Children are most commonly affected and the most frequent sites of bony lesions are the skull, femur, mandible, pelvis and spine. Some studies have demonstrated that LCH is a neoplastic hyperplasia of Langerhans cells. 2 -4 Some authors consider that clonality should be assessed sequentially in more patients with LCH, both at the time of disease presentation and during the course of the disease. 5 Monoclonality is a major characteristic of most tumours, whereas normal tissue and reactive hyperplasia tend to be polyclonal. 6 To the authors' knowledge, only a few cases that have investigated the clonality of *L Gong and W-D Zhang contributed equally to this work.
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Langerhans cells in LCH have been reported in the literature and different conclusions have been reached for different organs. 2, 3, 7, 8 Thus, the aim of the present study was to elucidate the clonality of Langerhans cells in LCH occurring in bone using a clonality assay based on X-chromosomal inactivation mosaicism in female somatic tissues and polymorphism of the androgen receptor (AR) gene. 
Materials and methods

SAMPLES
IMMUNOHISTOCHEMISTRY
Immunostaining was carried out using a streptavidin-labelled peroxidase (S-P) kit (KIT9730; Maixin Biotechnology Development Co., Ltd, Fuzhou, China) according to the manufacturer's instructions. The primary antibodies (undiluted) used in this study included mouse antihuman monoclonal antibodies against CD68, CD163, CD1a, CD34, leucocyte common antigen (LCA), CD20, CD45RO, CD99, CD30, CD15, desmin, nerve-specific enolase and nerve fibre rabbit antihuman polyclonal antibodies against CD117, S-100 protein, smooth muscle actin and human melanoma black (HMB)45, and a mouse antipig monoclonal antibody against vimentin. After the tissue sections had been deparaffinized, rehydrated in graded alcohols and incubated with hydrogen peroxide to block the activity of endogenous peroxidase, they were then incubated with the primary antibodies for 2 h at room temperature and washed three times in phosphate-buffered saline (PBS) (10 mM, pH 7.4). Then, biotinylated rabbit antimouse secondary antibodies were added to each section and incubated for 10 min at room temperature. After washing a final three times in 10 mM PBS the immunostaining was visualized using the S-P kit according to the manufacturer's instruction. All of the reagents for immunostaining were supplied by Maixin Biotechnology Development Co., Ltd.
MICRODISSECTION AND DNA EXTRACTION
Eight 10-µm thick tissue sections (1.0 × 1.0 cm), obtained from three different paraffin blocks for the three different patients, were placed on a UV-absorbing membrane for microdissection using a laser microdissection microscope (LMD6000; Leica Microsystems, Wetzlar, Germany). Briefly, after H & E staining, the slides were mounted on a microstat and Langerhans cells were then dissected by UV laser in a motorized optical beam scanning mode. The dissected cells fell by gravity into the cap of a microcentrifuge tube with a volume of 0.5 ml. The cap was filled with 40 µl lysate buffer (10% sodium dodecyl sulphate, 5 M sodium chloride, 1 M Tris-HCl and 0.5 M ethylenediaminetetraacetic acid) and 10 µl proteinase K (20 mg/ml). For each dissected lesion, surrounding fibrous connective tissue (from the same area) was also isolated and L Gong, W-D Zhang, Y-H Li et al.
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analysed as a control. The microcentrifuge tubes were placed in a 48 ºC water bath and after digestion with proteinase K and lysate buffer for 12 -20 h, the genomic DNA was examined by 2% agarose electrophoresis and stored at -20 ºC.
PCR AMPLIFICATION FOR CLONAL ASSAY
A nested polymerase chain reaction (PCR) was used to amplify the detected CAG polymorphism length of the short-tandem repeat in exon 1 of the AR gene loci, as described previously. 9 For the AR gene, 10 µl of each sample of genomic DNA extracted from lesion and control tissues was incubated with 5 U of HhaI (Promega, Madison, WI, USA) at 37°C for 3 h in a volume of 20 µl containing 2 µl of 10× reaction buffer. A 1 µl aliquot of each of the digested DNA samples was then subjected to nested PCR in 50 µl of reaction mixture containing 4 µl of 10 mM dNTP (Gibco BRL Life Technologies Inc., Gaithersburg, MD, USA), primers AR1A and AR1B (20 µM each) (sequence of AR1A, 5′-GAG GAG CTT TCC AGA ATC TG-3′; sequence of AR1B, 5′-CAT GGG CTT GGG GAG A-3′), 5 µl of 10× reaction buffer, 1.5 µl of 50 mM magnesium chloride and 2.5 U of Taq DNA polymerase (Gibco BRL). Amplification (predenaturation at 97°C for 5 min followed by 25 cycles of denaturation at 94°C for 40 s, annealing at 56°C for 50 s and elongation at 72°C for 1 min, and finally extension at 72°C for 15 min) was conducted using a PT-200 thermal cycler (MJ Research, Watertown, MA, USA). The PCR products (1 µl) from the first round of amplification were then used as templates for a second PCR reaction using primers AR2A and AR2B (sequence of AR2A, 5′-TCC AGA ATC TGT TCC AGA GC-3′; sequence of AR2B, 5′-TGG GGA GAA CCA TCC TCA CC-3′). The amplification procedure was the same as that in the first round. Finally, the amplification efficiency was checked by resolving PCR aliquots on 2% agarose gels. The PCR products (4 µl for each) were mixed with an equal volume of loading buffer (1 g/l xylene cyanole, 1 g/l bromophenol blue, in formamide) and resolved on an 8% polyacrylamide gel containing 8 mol/l urea using the miniVE vertical electrophoresis system (Amersham Biosciences, San Francisco, CA, USA) at 120 V for 4 h. Bands were visualized using silver staining.
ANALYSIS AND ASSESSMENT OF PCR PRODUCTS FOR CLONAL ASSAY
Images of the PCR products on the polyacrylamide gels were recorded and the intensity of the PCR bands for both alleles was quantified using an image-analysing system (LabWorks™, version 3.0; UVP Ltd, Cambridge, UK). A reduction in fluorescence intensity of at least 50% for either band when compared with the intensity of the bands obtained in the absence of HhaI digestion was used as an indicator of loss of X-chromosome inactivation mosaicism. 9 A corrected ratio (CR) was calculated using the ratio of the upper-band intensity to the lower-band intensity, or vice versa, of the same sample before and after digestion to give a CR value > 1. A CR value ≥ 2 was used to define loss of X-chromosome inactivation mosaicism.
Results
Microscopically, LCH lesions were accompanied by a variable admixture of Langerhans cells with a characteristic morphological appearance, eosinophils, giant cells, neutrophils, foamy cells and areas of fibrosis (Fig. 1A, 1B 1B) . Immunohistochemically, the Langerhans cells were positive for S-100 protein (Fig. 1C) , CD1a (Fig. 1D) and vimentin, and negative for CD68, CD163, CD99, nerve-specific enolase, nerve fibre rabbit antihuman polyclonal antibodies against CD117, CD34, desmin, smooth muscle actin, LCA, CD20, CD45RO, CD30, CD15 and HMB45.
The clonality assay demonstrated polymorphism for all three female samples at the AR gene loci. On the PCR polyacrylamide gel images, two bands were observed in the DNA samples obtained from Langerhans cells without HhaI digestion, whereas one of these bands disappeared after digestion with HhaI (Fig. 2) . In contrast, the intensity of the two bands was equal for the surrounding soft tissue with or without HhaI digestion (Fig. 2) . These results suggest that LCH can be interpreted as neoplastic hyperplasia.
Discussion
The aetiology and pathogenesis of LCH is unclear although abnormal clonal proliferation and accumulation of 
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Langerhans cells in various tissues and organs are characteristic. LCH can affect patients at any age, although more cases present in children. Yagci et al. 10 evaluated the clinicopathological features of 217 patients with LCH and found the median age at the time of diagnosis was 3.5 years and the male:female ratio was 1.8. The most common complaint at presentation was a bone lesion-related symptom. They found that any bone could be involved, with the possible exception of the hands and feet; the most common sites were the cranial vault, jaw, humerus, rib and femur. Radiographically, presentation was as an osteolytic lesion, often in the metophyseal area of long bones. 10 Diagnosis of LCH is based on radiographical changes and/or specific pathological findings and immunohistochemical staining, including an osteolytic lesion often occurring in the metaphyseal area of long bones, a variable admixture of Langerhans cells with characteristic morphological appearance, eosinophils, giant cells, neutrophils, foamy cells and areas of fibrosis, as well as Langerhans cells that are positive for CD1a and S-100 protein. 11 The pathological features observed in the three cases in the present study were similar to these, supporting the diagnosis of LCH. It is, however, important to differentiate LCH from other diseases, such as chronic osteomyelitis and Erdheim-Chester disease (ECD). Chronic osteomyelitis is mainly composed of plasma cells and lymph cells, while the characteristic Langerhans cells are absent. 12 ECD is a rare form of non-Langerhans histocytosis, characterized by xanthogranulomatous infiltration of foamy macrophages. 13 In intraskeletal LCH, cells may occasionally be found that resemble the lipid-laden histiocytes of ECD. A difference lies in the fact that Langerhans cells are arranged in a nested pattern and intermingle with inflammatory cells, including eosinophilic granulocytes, lymphocytes, neutrophilic granulocytes and plasmocytes. Immuno histo chemically, the cells in ECD are positive for CD68 and negative for CD1a, whereas staining for S-100 protein may be positive or negative.
Furthermore, lesions in ECD have been reported to be polyclonal in nature. 14, 15 Only a few cases in the literature have reported the clonality of Langerhans cells in LCH and different conclusions have been reached for different organs. 2, 3, 7, 8 In addition, because some forms behave in a relatively benign manner and are associated with an inflammatory cell infiltrate, it has been proposed that LCH might be a reactive disease. 16 Monoclonality is a main feature of most tumours, whereas normal and reactive hyperplastic lesions are polyclonal. 6 The clonality assay is based on X-chromosome inactivation mosaicism and polymorphism at the AR gene loci in female somatic cells. There are two X chromosomes within each female somatic cell, one of which is inactivated randomly by methylation during early embryogenesis, while the other preserves its genetic activity throughout life. The AR gene polymorphism shows different lengths of the CAG short-tandem repeat at exon 1. 17 After digestion with the methylation-sensitive restriction enzyme HhaI, normal and reactive hyperplastic tissues with polymorphism show two alleles with equal intensity. Neoplastic tissues show either of two alleles with obviously reduced intensity. 6 In the present study, the clonal assay demonstrated LCH to be a neoplastic lesion, which is in line with other studies and further confirms the nature of LCH.
Moreover, it is known that PCR-based clonality analysis occasionally produces a pseudomonoclonal or pseudopolyclonal result. 18 The major mechanism responsible for the pseudomonoclonal result is the patch-size concept. 19, 20 If progeny cells remain adjacent to each other after cell division, large patches of cells are formed, all of which contain an identical pattern of Xchromosome inactivation. Lesions arising from two, three or more cells within a patch will show the same pattern of X-chromosome inactivation, therefore appearing monoclonal. This concept is a particularly important consideration when using very small tissue samples obtained by microdissection. To avoid this problem, Diaz-Cano et al. 18 recommended the use of sample sizes of > 100 cells or 0.25 cm 2 . Although laser microdissection was performed in the present study in order to obtain pure Langerhans cell samples, the sample sizes were far larger than 100 cells. A pseudopolyclonal result may also be caused by contamination due to a heavy inflammatory cell infiltrate. The LCH lesions comprised various cells, including Langerhans cells, eosinophils, giant cells, neutrophils, foamy cells and areas of fibrosis. Laser microdissection was used in the present study in order to minimize such circumstances, so the study results are considered reliable. Additional studies with larger sample sizes are, however, necessary to prove conclusively the hypothesis that LCH is characterized by clonal proliferation.
